| Bioactivity | NoxA1ds is a highly efficacious and selective Nox1 (NADPH oxidase isoform 1) inhibitor. NoxA1ds establishes a critical interaction site for Nox1-NOXA1 binding required for enzyme activation. NoxA1ds can be used for the research of hypertension, atherosclerosis and neoplasia[1]. | ||||||
| Name | NoxA1ds | ||||||
| CAS | 1435893-78-9 | ||||||
| Shortening | EPVDALGKAKV-NH2 | ||||||
| Formula | C50H88N14O15 | ||||||
| Molar Mass | 1125.33 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
NoxA1ds
CAS: 1435893-78-9 F: C50H88N14O15 W: 1125.33
NoxA1ds is a highly efficacious and selective Nox1 (NADPH oxidase isoform 1) inhibitor. NoxA1ds establishes a critical i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.